ISIS 113715

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ISIS 113715, covering 2007-10-17 to 2008-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment [Phase 2]

See pricing